Andrew Graham

John Radcliffe Hospital

Papers

2

Total Citations

46

H-Index

2

About

Andrew Graham is a pioneering researcher in the field of telepathology, with a particular focus on its application in breast histopathology and quality assurance programs. His work has been instrumental in establishing telepathology as a viable alternative to conventional diagnostic pathology methods, particularly within the United Kingdom's healthcare system. Graham's most significant contribution is his rigorous clinical evaluation of robotic telepathology systems within the UK breast screening pathology quality assurance program. His landmark 2000 study, which has garnered 43 citations, demonstrated the clinical and technical utility of telepathology by conducting a structured trial involving 87 cases, providing compelling evidence for its real-world applicability. This research addressed a critical need in pathology services, exploring how remote diagnostic technologies could maintain diagnostic accuracy while improving accessibility and efficiency in breast cancer screening. His earlier 1999 work on robotic interactive telepathology further laid the groundwork for understanding accuracy benchmarks in external quality assurance schemes. Together, these studies positioned Graham as an early advocate for digital transformation in pathology, contributing foundational evidence that has helped shape the subsequent adoption of telepathology technologies in clinical and screening environments across the UK and beyond.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Trial of Telepathology As an Alternative Modality in Breast Histopathology Quality Assurance
43 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: John Radcliffe Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago